Skip to content
    Main Street Advisors logo

    Main Street Advisors

    Santa Monica, California, United StatesFounded 1997
    www.mainstreetadvisors.comLinkedIn
    Media & EntertainmentConsumerHealthcareFintechGaming

    Main Street Advisors is a boutique investment and merchant banking firm founded in 1997 by Paul Wachter. The firm serves as a strategic advisor to and invests capital alongside influential people and businesses in media, music, entertainment, and sports, targeting minority and non-control investment opportunities across consumer products, health & wellness, IT, and financial services.

    They made 2 investments in the last 12 months. Average disclosed round size is $49.0M (across 21 rounds with reported amounts).

    Find people at Main Street Advisors on Goldilocks AI

    Portfolio

    16

    Fund Size

    $1.1B

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Christine Banian

    Christine Banian

    Partner, President

    David Mossé

    David Mossé

    Partner, Head of Private Equity and Direct Investments

    Jay Potts

    Jay Potts

    Partner, Chief Financial Officer

    Steven Rindner

    Steven Rindner

    Partner, Head of Client Investments and Advisory

    Todd Rosen

    Todd Rosen

    Partner, General Counsel

    Robert Harris

    Robert Harris

    Director of Information Technology

    Ishu Chadha

    Ishu Chadha

    Principal

    Justin Yi

    Justin Yi

    Principal

    Miguel Hollander

    Miguel Hollander

    Principal

    Austen Smith

    Austen Smith

    Vice President

    Bob Morabia

    Bob Morabia

    Vice President

    Mona Sekhon

    Mona Sekhon

    Vice President, Investment Operations

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    22 investments
    CompanyRoundAmountDate
    MOSH logoMOSHSeries A$13MMay 2026
    Mosh logoMoshSeries A$13MJan 2026
    Pelage Pharmaceuticals logoPelage PharmaceuticalsSeries B$120MOct 2025
    Pelage Pharmaceuticals logoPelage PharmaceuticalsSeries A$14MFeb 2024
    StatusPRO logoStatusPROSeries A$20MFeb 2024
    Kate Farms logoKate FarmsSeries C$75MSep 2022
    ZenLedger logoZenLedgerSeries B$15MMay 2022
    Kate Farms logoKate FarmsSeries C$75MJan 2022
    NTWRK logoNTWRKSeries A$50MSep 2021
    MMahana TherapeuticsSeries B$61MAug 2021
    MMahanaSeries B$81MJan 2021
    Hyperice logoHypericeGrowth$48MOct 2020
    Hyperice logoHypericeSeries A$48MJan 2020
    Hound Labs logoHound LabsSeries D$30MAug 2019
    Hound Labs logoHound LabsSeries D$30MJan 2019
    Beautycon logoBeautyconUnknown$9MMar 2017
    BBeautyCon MediaSeries A$9MJan 2017
    Hound Labs logoHound LabsSeries B$8.1MJan 2017
    EVERFI logoEVERFIGrowth$190M—
    Noshable logoNoshableUnknown$10K—
    PPelageSeries B$120M—
    PPelageSeries A——

    Top Co-Investors

    GV5 shared
    YK Bioventures4 shared
    Visionary Ventures4 shared
    ARCH Venture Partners4 shared
    SC Holdings3 shared
    The Goldman Sachs Group, Inc.3 shared
    Benchmark3 shared
    Drake Ventures2 shared
    Morrison Seger Venture Capital Partners2 shared
    Live Nation2 shared
    Lux Capital2 shared
    JAZZ Venture Partners2 shared
    Icon Ventures2 shared
    Kaiser Permanente Ventures2 shared
    Novo Capital2 shared
    TitletownTech1 shared
    Wise Capital Partners LLP1 shared
    Alumni Ventures1 shared
    KB Partners1 shared
    Verizon Ventures1 shared

    Last updated: 20 October 2026